Global Hysterosalpingography (HSG) Market

Hysterosalpingography (HSG) Market size is expected to grow at a CAGR of 6.30% throughout the forecast period, reaching nearly US$ 3.96 Bn. by 2032.

Hysterosalpingography (HSG) Market Definition

Hysterosalpingography, or HSG, is an X-ray test to outline the internal shape of the uterus and show whether the fallopian tubes are blocked. It's also used to investigate miscarriages due to problems in the uterus.

To know about the Research Methodology :- Request Free Sample Report

Hysterosalpingography (HSG) Market Dynamics

The global hysterosalpingography market is driven by technological advancement in hysterosalpingography procedures and increasing benefits in the concerns of patient care. The increasing prevalence of genetic disorders like Down syndrome, ONTD, and other genetic disorders are the driving factors for the global market. Rising consanguineous relations and physical relation in them increase the consciousness in the couples, which help to grow the global hysterosalpingography market. Growing laboratory applications of non-invasive hysterosalpingography are the opportunity for the global market to detect the disorders before childbirth.

The emergence of new market entrants and local market players with low-cost products gives lucrative opportunities in the forecast period. The high availability of hysterosalpingography devices and the presence of a large number of manufacturers are expected to boost the demand for hysterosalpingography globally. The occurrence of infections and bleeding as well as complications faced during HSC testing may restrain the growth of the global market.

Hysterosalpingography (HSG) Market Segment Analysis:

The report groups the Global Hysterosalpingography (HSG) Market in different segments Application, and Region to forecast the revenues and analyze the market share of each segment over the forecast period.

Based on Application, the Global Hysterosalpingography (HSG) Market is segmented into Uterine Malformations, Asherman's syndrome, Tubal occlusion, Pelvic inflammatory disease. The Uterine malformations segment was dominant in 2021 and is expected to command a market share of xx% by 2029. Birth cases having the birth defect and the unknown causes of a congenital anomaly are detected recently by the hysterosalpingography laboratory techniques.

The prevalence of uterine malformation is estimated to be 6.7% in the general population, slightly higher in the infertility population, and significantly higher in a population of women with a history of recurrent miscarriages. These increasing numbers of patients are driving the global market.

The technological developments in the 3-dimensional ultrasound or magnetic resonance image-guided systems along with hysterosalpingography procedures are giving the wide opportunity for the global market.

Recent Development: Hysterosalpingography (HSG) Market

Hysterosalpingography (HSG) Market Regional Analysis:

North America is expected to command the largest market share of xx% by 2032.

Hysterosalpingography (HSG) has become a commonly performed examination in North America due to recent advances and improvements as well as the increasing popularity of reproductive medicine. Ongoing research on the HSC conducts for the detection of abnormalities related to the uterus and fallopian tubes. An increase in the number of pregnant women detected at HSG includes congenital anomalies, polyps, leiomyomas, surgical changes, synechiae, and adenomyosis.

Professionals of North America estimated that HSG remains a valuable tool in the evaluation of the uterus and fallopian tubes. The radiologists from the region have the operation with HSG techniques operation and the knowledge about interpretation of HSG images are the growth factors for the global market in this region.

The objective of the report is to present a comprehensive analysis of the Global Hysterosalpingography (HSG) Market to the stakeholders in the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.

The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding the Global Hysterosalpingography (HSG) Market dynamics, structure by analyzing the market segments and projects the Global Hysterosalpingography (HSG) Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Hysterosalpingography (HSG) Market make the report investor’s guide.

Hysterosalpingography (HSG) Market Scope: Inquire before buying

Hysterosalpingography (HSG) Market, by Region:

• Asia Pacific
• North America
• Europe
• Latin America
• Middle East Africa

Hysterosalpingography (HSG) Market Key Players

• GE Healthcare
• Siemens Healthineers
• Canon Medical Systems Corporation
• Fujifilm Holdings Corporation
• Koninklijke Philips N.V.
• Carestream Health
• Shimadzu Corporation
• Konica Minolta
• Samsung Electronics
• Hitachi Ltd.
• Hologic Inc.
• CooperSurgical
• Cook Medical
• Medtronic plc
• Boston Scientific Corporation
• Cardinal Health
• Teleflex Incorporated
• Olympus Corporation
• KARL STORZ SE & Co. KG
• Stryker Corporation
• Richard Wolf GmbH
• Braun Melsungen AG
• MedGyn Products Inc.
• Bayer AG
• Bracco Imaging S.p.A.
• Guerbet Group
• Merit Medical Systems
• AngioDynamics
• Terumo Corporation

Frequently Asked Questions:

1. Which region has the largest share in Global Hysterosalpingography (HSG) Market?
Ans: North America region holds the highest share in 2025.

2. What is the growth rate of Global Hysterosalpingography (HSG) Market?
Ans: The Global Hysterosalpingography (HSG) Market is growing at a CAGR of 6.30% during forecasting period 2026-2032.

3. What is scope of the Global Hysterosalpingography (HSG) market report?
Ans: Global Hysterosalpingography (HSG) Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Hysterosalpingography (HSG) market?
Ans: The important key players in the Global Hysterosalpingography (HSG) Market are – Fairview Health Services, Atlantic OB-GYN, TRA-MINW, Shady Grove Fertility, Southwest Medical Center, Summit Medical Group, Reproductive Medicine Institute, Crozer-Keystone Health System, South Florida Institute for Reproductive Medicine and Lake Imaging, Halotech DNA, SCSA Diagnostics Inc., Andrology Solutions, Zydus Cadila Healthcare Ltd, Androvia LifeSciences, Aetna Inc., Bayer Healthcare, and EMD Serono Inc

5. What is the study period of this market?
Ans: The Global Hysterosalpingography (HSG) Market is studied from 2025 to 2032.